Poland· PL-100478727
Procysbi
A mercaptamine product containing mercaptamini bitartras, registered in Poland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Mercaptamine · ATC A16AA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mercaptamine costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mercaptamine · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$589.95
The record
At a glance
URPL (Poland)- Active substance
- Mercaptamini bitartras
- Manufacturer
- Chiesi Farmaceutici S.p.A.
- Country
- Poland (PL)
- ATC code
- A16AA04
- ATC class
- Mercaptamine
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumProcysbi 300 mgChiesi Farmaceutici
- CzechiaPROCYSBIChiesi Farmaceutici S.p.A., Parma
- FinlandPROCYSBIChiesi Farmaceutici S.p.A.
- IrelandPROCYSBI 300 mg gastro-resistant granulesChiesi Farmaceutici S.p.A.
- IcelandProcysbiChiesi Farmaceutici S.p.A.*
- NetherlandsProcysbi 300 mg, maagsapresistent granulaatChiesi Farmaceutici S.p.A.
- SwedenPROCYSBI 300 mg EnterogranulatChiesi Farmaceutici S.p.A.
- United StatesCYSTADROPSRECORDATI RARE DISEASES, INC.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bea01235-1325-4a6d-9280-cbbf4a53f4bc GET /v1/drugs/bea01235-1325-4a6d-9280-cbbf4a53f4bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulat dojelitowy",
"source": "urpl",
"strength": "300 mg",
"packaging": "Rpz ¦ EU/1/13/861/004 ¦ 148571\n120 sasz.",
"substance": "Mercaptamini bitartras 300 mg",
"common_name": "Mercaptamini bitartras",
"pl_product_id": "100478727",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.